Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr. Schipper received his M.D. and Ph.D. (Neuroendocrinology) degrees at McGill University in 1982. He studied Internal Medicine at McGill University, Neurology at Columbia University, and Endocrinology at Tufts University. Dr. Schipper is currently tenured Professor of Neurology and Medicine (Geriatrics) at McGill, staff neurologist at the Jewish General Hospital, and consultant at other Montreal institutions. He is founding director of the Centre for Neurotranslational Research, a Biomedical Redox Laboratory and the Alzheimer Risk Assessment Clinic at the Jewish General Hospital, and a founding scientist of Molecular Biometrics Inc. RESEARCH & TEACHING: Dr. Schipper’s long-standing research interests are in the fields of Oxidative Stress, Brain Aging and Neurodegenerative Diseases. Three papers (1980-3) emanating from his doctoral thesis provided the earliest published evidence that chronic exposure to ovarian estrogen promotes aging-related degenerative changes in rodent brain regions implicated in reproductive senescence and the development of polycystic ovaries. Since 1990, his laboratory has contributed a large body of evidence and novel theory concerning the role of heme oxygenase-1 (HO-1) and iron-containing astroglia in CNS senescence and free radical-related neurodegenerative disorders. A major research focus of his laboratory is the development of blood-based biological markers for the early diagnosis and prognosis of sporadic Alzheimer disease and other degenerative human CNS afflictions. Dr. Schipper’s laboratory has received generous support from the Canadian Institutes for Health Research (CIHR), the Fonds de la Recherche en Santé du Québec and several other Canadian and American funding agencies. Dr. Schipper has published over 190 articles on various aspects of the redox neurosciences and related topics in peer-reviewed journals and has filed 14 patents and 3 copyrights. In 1998, he edited a first book of its genre entitled Astrocytes in Brain Aging and Neurodegeneration (RG Landes Co.). He co-edited a volume for the Annals of the New York Academy of Sciences on brain metals in 2004, and co-edited a 3-volume text on Principles of Free Radical Biomedicine (2012). Dr. Schipper recently completed his tenure as Chair of the Biological & Clinical Aspects of Aging Committee at the CIHR. He served on the Editorial Board of the Journal of Neurochemistry and is a member of numerous professional societies. Dr. Schipper is the recipient of numerous honours and awards, including the 2009 BIOQuebec Genesis Technology Transfer Award and the 2010 Frost&Sullivan North American Technology Innovation Award. He has given over 170 invited lectures, seminars and presentations in Canada, the United States, Europe and Israel. At McGill University and the Jewish General Hospital, Dr. Schipper provides basic and clinical teaching in the neurosciences and coordinates an interdisciplinary course on Free Radical Biomedicine in the Faculty of Science.
A major research focus of his laboratory is the development of blood-based biological markers for the early diagnosis and prognosis of sporadic Alzheimer disease and other degenerative human CNS afflictions
Paul Kearney, Nathan L. Currier, Daniel Chelsky, Clarissa Desjardins, Patrice Hugo, Joanna Hunter, Eustache Paramithiotis, Marc Riviere, Olivier Maes, Howard M. Cherkow, Hyman M. Schipper
Research Article: J Proteomics Bioinform Vol.1.7 315- 328(2008)